Tesamorelin / Ipamorelin Blend

This research blend pairs tesamorelin (a fat-targeting hormone signal) with ipamorelin (a clean growth-hormone trigger) so both pathways can be studied together.

It's studied in weight and performance research — visceral-fat signaling alongside natural-style hormone pulses.

Cell models evaluate whether the two pathways activate together. No human results; any benefit is unproven.

Distinguishes established clinical findings from early human trials, animal experiments, or laboratory cell culture findings. No human dosing, injection instructions, or treatment recommendations are provided.

This blend is an unapproved research mixture. It is not for human, therapeutic, or clinical use.

BBOHC LABS research reagents are non-clinical materials. An FDA approval for a finished medicine containing the same active ingredient does not imply that BBOHC's investigational research vial is FDA-approved.

Laboratory research material only.

• Comparative growth hormone pulse release under dual GHRH and ghrelin receptor stimulation.

Specific citations are provided for literature context. Product purity & lot verification documentation available on request.